IDXX insider receives 48 shares in stock awards
By AlphaYouPublished Form 4
HOOLEY JOSEPH L
Reporting filer
HOOLEY JOSEPH L reported 48 shares of Common Stock in IDEXX LABORATORIES INC /DE as grants or awards dated 2026-10-30. The Form 4 was disclosed on Nov 3, 2026. These were stock awards, not open-market purchases.
- Disclosed
- Nov 3, 2026
Reported details
1 entry| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Common Stock | HOOLEY JOSEPH L | 2026-10-30 | A | Grant or award | 48 | 551.21 | 373 | 4 days | Filed terms
|
Common Stock
- Owner
- HOOLEY JOSEPH L
- Date
- 2026-10-30
- Code
- A
- Action
- Grant or award
- Quantity
- 48
- Price
- 551.21
- Following holdings
- 373
- Reporting delay
- 4 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-10-30
- transaction Form Type: 4
- transaction Code: A
- equity Swap Involved: 0
- transaction Shares: 48
- id: F1
- transaction Price Per Share: 551.21
- transaction Acquired Disposed Code: A
- shares Owned Following Transaction: 373
- direct Or Indirect Ownership: D
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- HOOLEY JOSEPH L: Director.
- F1: Represents deferred stock units acquired pursuant to the IDEXX Laboratories, Inc. Director Deferred Compensation Plan (the 'Plan') in accordance with Rule 16b-3. The number of deferred stock units, rounded up or down to the nearest whole unit, is determined by dividing the amount of cash compensation deferred pursuant to the Plan ($26,250.00) by the closing price of IDEXX Laboratories, Inc. common stock on the date of the deferral, or if no such price is reported for that date, the closing price for the next preceding date for which such price was reported. Each deferred stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The deferred stock units vest immediately upon grant and are payable only as common stock as soon as practicable following the Director's resignation from the Board of Directors or on such other nondiscretionary and objectively determinable date(s) selected in accordance with the terms of the Plan.
Original sources
Prepared automatically from public filing data. Report a correction.